Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-13 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-09 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-06 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-05 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |